Skip to Main Content

Author Details

Robert L Foote
Mayo Clinic
1988
264
61
PMIDPaper TitleJournal TitlePublished Year
36222355Adenoid cystic carcinoma of the head and neck: Patterns of recurrence and implications for intensity-modulated radiotherapy.Head Neck2023
37509376A Radiomics-Based Classifier for the Progression of Oropharyngeal Cancer Treated with Definitive Radiotherapy.Cancers (Basel)2023
37461414Modelling small block aperture in an in-house developed GPU-accelerated Monte Carlo-based dose engine for pencil beam scanning proton therapy.ArXiv2023
37152485Clinicopathologic Factors and Their Association with Outcomes of Salivary Duct Carcinoma: A Multicenter Experience.Adv Radiat Oncol2023
37183678Early Impact of Proton Beam Therapy on Electrophysiological Characteristics in a Porcine Model.Circ Arrhythm Electrophysiol2023
37046705Rotating Gantries Provide Individualized Beam Arrangements for Charged Particle Therapy.Cancers (Basel)2023
36980545Pragmatic, Prospective Comparative Effectiveness Trial of Carbon Ion Therapy, Surgery, and Proton Therapy for the Management of Pelvic Sarcomas (Soft Tissue/Bone) Involving the Bone: The PROSPER Study Rationale and Design.Cancers (Basel)2023
36972299The effect of common dental fixtures on treatment planning and delivery for head and neck intensity modulated proton therapy.J Appl Clin Med Phys2023
37297019Comparing Oncologic Outcomes and Toxicity for Combined Modality Therapy vs. Carbon-Ion Radiotherapy for Previously Irradiated Locally Recurrent Rectal Cancer.Cancers (Basel)2023
37091160Validation of clinical acceptability of deep-learning-based automated segmentation of organs-at-risk for head-and-neck radiotherapy treatment planning.Front Oncol2023
36681089Radiotherapy and paclitaxel plus pazopanib or placebo in anaplastic thyroid cancer (NRG/RTOG 0912): a randomised, double-blind, placebo-controlled, multicentre, phase 2 trial.Lancet Oncol2023
3660336430-day morbidity and mortality after transoral robotic surgery for human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma: A retrospective analysis of two prospective adjuvant de-escalation trials (MC1273 & MC1675).Oral Oncol2023
36309077A Prospective Study of Mucosal Sparing Radiation Therapy in Resected Oropharyngeal Cancer Patients.Int J Radiat Oncol Biol Phys2023
34715395Outcomes and Patterns of Recurrence for Anaplastic Thyroid Cancer Treated With Comprehensive Chemoradiotherapy.Pract Radiat Oncol2022
35809230Merkel cell carcinoma of unknown primary: Clinical presentation and outcomes.J Surg Oncol2022
35774126National Effort to Re-Establish Heavy Ion Cancer Therapy in the United States.Front Oncol2022
35443080GPU-accelerated Monte Carlo-based online adaptive proton therapy: A feasibility study.Med Phys2022
35675850Long-Term Toxic Effects, Swallow Function, and Quality of Life on MC1273: A Phase 2 Study of Dose De-escalation for Adjuvant Chemoradiation in Human Papillomavirus-Positive Oropharyngeal Cancer.Int J Radiat Oncol Biol Phys2022
35820062Exploratory study of seed spots analysis to characterize dose and linear-energy-transfer effect in adverse event initialization of pencil-beam-scanning proton therapy.Med Phys2022
35816454Development of transparent eye shields for total skin electron beam radiotherapy.J Appl Clin Med Phys2022
35814859The Number of Radiographically Positive Lymph Nodes Further Stratifies Patient Survival Among Clinical N1 Patients With Human Papillomavirus-Associated Oropharyngeal Cancer.Adv Radiat Oncol2022
36439436Collimating individual beamlets in pencil beam scanning proton therapy, a dosimetric investigation.Front Oncol2022
36420184Evolutionary Action Score of <i>TP53</i> Analysis in Pathologically High-Risk Human Papillomavirus-Negative Head and Neck Cancer From a Phase 2 Clinical Trial: NRG Oncology Radiation Therapy Oncology Group 0234.Adv Radiat Oncol2022
35875126The Majority of United States Citizens With Cancer do not Have Access to Carbon Ion Radiotherapy.Front Oncol2022
36106100Scalable radiotherapy data curation infrastructure for deep-learning based autosegmentation of organs-at-risk: A case study in head and neck cancer.Front Oncol2022
36129387Low postoperative lymphocyte count increases risk of progression in human papillomavirus associated oropharyngeal cancer.Head Neck2022
35960865Virtual particle Monte Carlo: A new concept to avoid simulating secondary particles in proton therapy dose calculation.Med Phys2022
35157995Detectable Postoperative Circulating Tumor Human Papillomavirus DNA and Association with Recurrence in Patients With HPV-Associated Oropharyngeal Squamous Cell Carcinoma.Int J Radiat Oncol Biol Phys2022
34859516An comparison of acute toxicities and patient-reported outcomes between intensity-modulated proton therapy and volumetric-modulated arc therapy after ipsilateral radiation for head and neck cancers.Head Neck2022
35311159Empirical Relative Biological Effectiveness (RBE) for Mandible Osteoradionecrosis (ORN) in Head and Neck Cancer Patients Treated With Pencil-Beam-Scanning Proton Therapy (PBSPT): A Retrospective, Case-Matched Cohort Study.Front Oncol2022
35305269Technical note: Evaluation and second check of a commercial Monte Carlo dose engine for small-field apertures in pencil beam scanning proton therapy.Med Phys2022
34994795Comparison of Oncologic Outcomes and Treatment-Related Toxicity of Carbon Ion Radiotherapy and En Bloc Resection for Sacral Chordoma.JAMA Netw Open2022
34843119Per-voxel constraints to minimize hot spots in linear energy transfer-guided robust optimization for base of skull head and neck cancer patients in IMPT.Med Phys2022
34509079The role of total parotidectomy in high-grade parotid malignancy: A multisurgeon retrospective review.Am J Otolaryngol2022
32969095Human papillomavirus oropharynx carcinoma: Aggressive de-escalation of adjuvant therapy.Head Neck2021
35530183Nuclear Fragmentation Imaging for Carbon-Ion Radiation Therapy Monitoring: an In Silico Study.Int J Part Ther2021
33644935Survival outcomes in locally advanced cutaneous squamous cell carcinoma presenting with clinical perineural invasion alone.Head Neck2021
33640577Risk groups of laryngeal cancer treated with chemoradiation according to nomogram scores - A pooled analysis of RTOG 0129 and 0522.Oral Oncol2021
337289992021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer.Thyroid2021
33752487Disease Profile and Oncologic Outcomes After Delayed Diagnosis of Human Papillomavirus-Associated Oropharyngeal Cancer.Otolaryngol Head Neck Surg2021
33889375A case of metachronous bilateral secretory carcinoma.Rare Tumors2021
34814068Correlation between radiographic and pathologic lymph node involvement and extranodal extension via CT and PET in HPV-associated oropharyngeal cancer.Oral Oncol2021
33958052The Role of Biological Effective Dose in Predicting Obliteration After Stereotactic Radiosurgery of Cerebral Arteriovenous Malformations.Mayo Clin Proc2021
34285958Work Outcomes after Intensity-Modulated Proton Therapy (IMPT) versus Intensity-Modulated Photon Therapy (IMRT) for Oropharyngeal Cancer.Int J Part Ther2021
34285955Oncologic Outcomes for Head and Neck Skin Malignancies Treated with Protons.Int J Part Ther2021
34285957Initial Experience with Proton Beam Therapy for Differentiated Thyroid Cancer.Int J Part Ther2021
34285956Intensity-Modulated Proton Therapy (IMPT) Treatment of Angiosarcoma of the Face and Scalp.Int J Part Ther2021
34285942A Systematic Review on Re-irradiation with Charged Particle Beam Therapy in the Management of Locally Recurrent Skull Base and Head and Neck Tumors.Int J Part Ther2021
34306932Delaying Postoperative Radiotherapy in Low-Grade Esthesioneuroblastoma: Is It Worth the Wait?J Neurol Surg B Skull Base2021
34306928Induction Therapy Prior to Surgical Resection for Patients Presenting with Locally Advanced Esthesioneuroblastoma.J Neurol Surg B Skull Base2021
  • 1 - 50 of 264

Recommended Authors

University of California San Francisco
Career Start Year 2017
Number of shared co-authors 2
University of California San Francisco
Career Start Year 2016
Number of shared co-authors 0
Princess Margaret Cancer Center
Career Start Year 2015
Number of shared co-authors 5
Stanford University
Career Start Year 2014
Number of shared co-authors 6
Rush University Medical Center
Career Start Year 2013
Number of shared co-authors 3
Vanderbilt University Medical Center
Career Start Year 2012
Number of shared co-authors 1
National Cancer Centre Singapore
Career Start Year 2011
Number of shared co-authors 12
Princess Margaret Cancer Centre/University Health Network, University of Toronto
Career Start Year 2004
Number of shared co-authors 11
University of Western Ontario
Career Start Year 2000
Number of shared co-authors 10
University of Colorado School of Medicine
Career Start Year 2000
Number of shared co-authors 8
Perelman School of Medicine, University of Pennsylvania
Career Start Year 2000
Number of shared co-authors 1
Cleveland Clinic
Career Start Year 2000
Number of shared co-authors 10
Maastricht University Medical Centre
Career Start Year 1999
Number of shared co-authors 9
Stanford University
Career Start Year 1999
Number of shared co-authors 12
University of California san francisco
Career Start Year 1998
Number of shared co-authors 1
Massachusetts General Hospital and Harvard Medical School
Career Start Year 1997
Number of shared co-authors 4
Leiden University Medical Center
Career Start Year 1997
Number of shared co-authors 4
Taussig Cancer Institute, Cleveland Clinic
Career Start Year 1994
Number of shared co-authors 6
Western University and London Regional Cancer Program
Career Start Year 1994
Number of shared co-authors 2
University of Toronto, Princess Margaret Cancer Centre, University Health Network
Career Start Year 1993
Number of shared co-authors 10
Princess Margaret Cancer Centre
Career Start Year 1992
Number of shared co-authors 6
Oregon Health & Science University
Career Start Year 1991
Number of shared co-authors 3
Oregon Health & Science University
Career Start Year 1990
Number of shared co-authors 5
Proton Therapy Center- Northwestern University
Career Start Year 1989
Number of shared co-authors 4
Radboud University Medical Center
Career Start Year 1987
Number of shared co-authors 5
University of Antwerp
Career Start Year 1987
Number of shared co-authors 1
Fondazione IRCCS Istituto Nazionale dei Tumori and University of Milan
Career Start Year 1987
Number of shared co-authors 9
Massachusetts General Hospital
Career Start Year 1982
Number of shared co-authors 4
University of California San Francisco
Career Start Year 1981
Number of shared co-authors 2
Duke University Medical Center
Career Start Year 1978
Number of shared co-authors 1

Collaborators

Mayo Clinic
Co-authored papers 40
2Mayo Clinic
Co-authored papers 27
Mayo Clinic
Co-authored papers 23
Mayo Clinic
Co-authored papers 17
Memorial Sloan Kettering Cancer Center
Co-authored papers 8
Mayo Clinic
Co-authored papers 8
Mayo Clinic
Co-authored papers 8
Mayo Clinic
Co-authored papers 7
MD Anderson Cancer Center
Co-authored papers 6
Mayo Clinic School of Medicine, Mayo Clinic
Co-authored papers 6
Inova Health System
Co-authored papers 6
Co-authored papers 5
Memorial Sloan Kettering Cancer Center
Co-authored papers 5
Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Co-authored papers 5
Mayo Clinic
Co-authored papers 4
Dana-Farber Cancer Institute, Harvard Medical School
Co-authored papers 4
Mayo Clinic
Co-authored papers 4
Spanish National Cancer Research Center (CNIO)
Co-authored papers 4
Mayo Clinic
Co-authored papers 4
University of Colorado School of Medicine
Co-authored papers 4
Mayo Clinic
Co-authored papers 4
Mayo Clinic
Co-authored papers 3
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
Evidence Foundation
Co-authored papers 2
Mayo Clinic
Co-authored papers 2
Mayo Clinic Jacksonville
Co-authored papers 2
Mayo Clinic
Co-authored papers 2
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
Mayo Clinic College of Medicine and Science
Co-authored papers 2
Mayo Clinic
Co-authored papers 2